-
21
RENAL DAMAGE WITH MALIGNANT NEOPLASMS
Published 2015-01-01“…The relationship between renal damage and malignant neoplasms is one of the most actual problems of the medicine of internal diseases. …”
Get full text
Article -
22
-
23
BENIGN URETHRAL NEOPLASMS IN WOMEN
Published 2020-09-01“…The review article presents current data on the diagnosis and treatment of benign urethral neoplasms (BUN) in women. BUNs are common diseases, manifest with express clinical symptoms and significantly impair the quality of life of patients. …”
Get full text
Article -
24
Mutant Calreticulin in the Myeloproliferative Neoplasms
Published 2020-02-01“…Mutations in the gene for calreticulin (CALR) were identified in the myeloproliferative neoplasms (MPNs) essential thrombocythaemia (ET) and primary myelofibrosis (MF) in 2013; in combination with previously described mutations in JAK2 and MPL, driver mutations have now been described for the majority of MPN patients. …”
Get full text
Article -
25
-
26
Autoimmune Complications in Hematologic Neoplasms
Published 2021-03-01“…Autoimmune cytopenias (AICy) and autoimmune diseases (AID) can complicate both lymphoid and myeloid neoplasms, and often represent a diagnostic and therapeutic challenge. …”
Get full text
Article -
27
Extracellular Vesicles in Myeloid Neoplasms
Published 2022-08-01“…Myeloid neoplasms arise from malignant primitive cells, which exhibit growth advantage within the bone marrow microenvironment (BMM). …”
Get full text
Article -
28
Management of primary neoplasms of the appendix
Published 2017-01-01Subjects: Get full text
Article -
29
-
30
-
31
Recent Advances in Pancreatic Neoplasms
Published 2021-10-01“…Pancreatic neoplasms, both primary and secondary, include different pathological entities with variable biological behavior and, consequently, different treatment modalities [...]…”
Get full text
Article -
32
Endoglin in head and neck neoplasms
Published 2023-02-01“…In this review we discuss the role of endoglin as a possible marker of carcinogenesis, as well as a potential target for antibody-based therapies in the neoplasms of the head and neck region.…”
Get full text
Article -
33
-
34
-
35
-
36
Neuroendocrine Neoplasms of the Gynecologic Tract
Published 2022-04-01“…Gynecological tract neuroendocrine neoplasms (NEN) are rare, aggressive tumors from endocrine cells derived from the neuroectoderm, neural crest, and endoderm. …”
Get full text
Article -
37
Interferons in the treatment of myeloproliferative neoplasms
Published 2024-02-01“…Interferons are cytokines with immunomodulatory properties and disease-modifying effects that have been used to treat myeloproliferative neoplasms (MPNs) for more than 35 years. The initial use of interferons was limited due to difficulties with administration and a significant toxicity profile. …”
Get full text
Article -
38
Myeloproliferative neoplasm stem cells
Published 2017“…Myeloproliferative neoplasms (MPNs) arise in the hematopoietic stem cell (HSC) compartment as a result of the acquisition of somatic mutations in a single HSC that provides a selective advantage to mutant HSC over normal HSC and promotes myeloid differentiation to engender a myeloproliferative phenotype. …”
Journal article -
39
Serous cystic neoplasms of the pancreas
Published 2005“…Pancreatic serous neoplasms are rare but account for the most common type of pancreatic cystic neoplasms. …”
Journal article -
40
Impact of Autoimmune Gastritis on Occurrence of Metachronous Gastric Neoplasms after Endoscopic Resection for Gastric Neoplasms
Published 2023-10-01Subjects: “…metachronous gastric neoplasms…”
Get full text
Article